ライフサイエンスコーパス: epithelial-to-mesenchymal transition

1 ponents and their regulators associated with epithelial to mesenchymal transition.

2 a result SNAI1 is stabilized, triggering an epithelial to mesenchymal transition.

3 e and altered the expressions of markers for epithelial to mesenchymal transition.

4 nown roles of CCN2 in promoting fibrosis and epithelial to mesenchymal transition.

5 24(+)CD29(+) cells exhibited features of the epithelial to mesenchymal transition.

6 We found that it induces reversion of epithelial to mesenchymal transition.

7 gulation of AKT/mTOR or in those involved in epithelial to mesenchymal transition.

8 , including cell cycle arrest, apoptosis and epithelial-to-mesenchymal transition.

9 poorly differentiated state with features of epithelial-to-mesenchymal transition.

10 (MUC1-CT) represent initiating steps in the epithelial-to-mesenchymal transition.

11 static potential through the upregulation of epithelial-to-mesenchymal transition.

12 arcinomas marked by poor differentiation and epithelial-to-mesenchymal transition.

13 king induction of many genes associated with epithelial-to-mesenchymal transition.

14 on, motility, and invasion without affecting epithelial-to-mesenchymal transition.

15 m hematopoietic cells, EndoMT, or epicardial epithelial-to-mesenchymal transition.

16 enhancing expression of the genes related to epithelial-to-mesenchymal transition.

17 -regulated in mouse ESCs--key players in the epithelial-to-mesenchymal transition.

18 ly gain such migratory capability through an epithelial-to-mesenchymal transition.

19 levels of CDH1, an important contributor to epithelial-to-mesenchymal transition.

20 sed extracellular matrix, cell adhesion, and epithelial-to-mesenchymal transition.

21 onize distant sites, including the so-called epithelial-to-mesenchymal transition.

22 re correct epithelial cell shape and prevent epithelial-to-mesenchymal transitions.

23 These tumors display features of epithelial-to-mesenchymal transition, a cellular state a

24 pression in mammary epithelial cells induced epithelial-to-mesenchymal transition, a morphological an

25 r ribavirin treatment suppressed features of epithelial-to-mesenchymal transition, a process crucial

26 is rapid, reversible and characterized by an epithelial to mesenchymal transition and a switch from d

27 sion of genes that regulate stemness and the epithelial to mesenchymal transition and inhibited clono

28 catenin signaling acts as a switch to induce epithelial to mesenchymal transition and promote colorec

29 n of the miR-200 target ZEB1, stimulates the epithelial to mesenchymal transition and ultimately resu

30 in tumor progression and resistance, such as epithelial-to-mesenchymal transition and cell adhesion p

31 ors, including several genes involved in the epithelial-to-mesenchymal transition and developmental p

32 ins fail to form adhesion junctions, undergo epithelial-to-mesenchymal transition and generate >100-m

33 PEB2B isoform inhibited pathways driving the epithelial-to-mesenchymal transition and hypoxic respons

34 aling cascade culminating in Slug induction, epithelial-to-mesenchymal transition and increased invas

35 the posterior side of the embryo undergo an epithelial-to-mesenchymal transition and ingress through

36 Several pathways are involved in the epithelial-to-mesenchymal transition and ingression of m

37 -activators whose dysfunction contributes to epithelial-to-mesenchymal transition and malignant trans

38 invasive abilities and higher expression of epithelial-to-mesenchymal transition and mammary stem ce

39 mals, various in vitro and in vivo models of epithelial-to-mesenchymal transition and metastasis, an

40 reas loss of NR4A1 inhibits TGF-beta-induced epithelial-to-mesenchymal transition and metastasis, sli

41 on protein products of genes instrumental to epithelial-to-mesenchymal transition and metastasis.

42 At this level, Numb loss associates with the epithelial-to-mesenchymal transition and results in diff

43 dergo an order-to-disorder transition via an epithelial-to-mesenchymal transition and sort symmetrica

44 lasts derived miR-409-induced tumorigenesis, epithelial-to-mesenchymal transition and stemness of the

45 henotypes were also affected at the level of epithelial-to-mesenchymal transition and the ERK1/2 sign

46 rs behind the elusive switch that drives the epithelial-to-mesenchymal transition and the mesenchymal

47 -8), real-time polymerase chain reaction for epithelial-to-mesenchymal transition and tight junction

48 ures and exhibited features of self-renewal, epithelial-to-mesenchymal transition and tumor initiatio

49 e report the novel functions of PHF8 in EMT (epithelial to mesenchymal transition) and breast cancer

50 ive tissue growth factor (CTGF)], markers of epithelial to mesenchymal transition, and more recently

51 y aspects of normal cell behavior, including epithelial-to-mesenchymal transition, and aberrant signa

52 the Hedgehog (Hh) pathway is associated with epithelial-to-mesenchymal transition, and activation of

53 s, including metastasis, therapy resistance, epithelial-to-mesenchymal transition, and angiogenesis.

54 differentiated tumors with enhanced hypoxia, epithelial-to-mesenchymal transition, and cancer stem ce

55 issue remodeling, cytoskeletal organization, epithelial-to-mesenchymal transition, and cellular migra

56 including profibrotic genes, genes promoting epithelial-to-mesenchymal transition, and genes associat

57 r stemness, angiogenesis, stroma deposition, epithelial-to-mesenchymal transition, and metastasis for

58 minal layer, led epithelial cells to undergo epithelial-to-mesenchymal transition, and resulted in la

59 al and resistance to environmental stresses, epithelial-to-mesenchymal transition, and the emergence

60 regulation, extracellular matrix remodeling, epithelial-to-mesenchymal transition, and the enrichment

61 cal processes, including tissue homeostasis, epithelial-to-mesenchymal transition, and wound repair.

62 the context of myotonic dystrophy type 1 and epithelial-to-mesenchymal transition, as well as splicin

63 Zeb2 is known to control epithelial to mesenchymal transition, but its role in im

64 Analysis of epithelial-to-mesenchymal transition, cell adhesion, and

65 l compartment downregulated Foxa2, foregoing epithelial-to-mesenchymal transition designated by loss

66 As metastasizing tumor cells undergo epithelial to mesenchymal transition during the initiati

67 in inflammation, cell growth, migration, and epithelial to mesenchymal transition during tumor develo

68 During epithelial-to-mesenchymal transition, E- to N-cadherin s

69 6-E7 proteins augmented invasion and induced epithelial to mesenchymal transition (EMT) accompanied b

70 (UTR) nucleic acid regulatory motif, driving epithelial to mesenchymal transition (EMT) and metastasi

71 etion of these kinesins does not reverse the epithelial to mesenchymal transition (EMT) caused by mut

72 tion with canonical Wnt signaling during the epithelial to mesenchymal transition (EMT) from NMP to m

73 promotes aberrant splicing and expression of epithelial to mesenchymal transition (EMT) genes, and ac

74 Activation of the epithelial to mesenchymal transition (EMT) genetic progr

75 The epithelial to mesenchymal transition (EMT) imparts disea

76 within the perivascular niche have undergone epithelial to mesenchymal transition (EMT) in a primary

77 Previous studies have proposed that epithelial to mesenchymal transition (EMT) in breast can

78 Epithelial to mesenchymal transition (EMT) in cancer cel

79 icroenvironment and acts as a key inducer of epithelial to mesenchymal transition (EMT) in lung cance

80 Epithelial to mesenchymal transition (EMT) is an essenti

81 he exact molecular mechanism associated with epithelial to mesenchymal transition (EMT) may be crucia

82 epatic metastasis frequently correlates with epithelial to mesenchymal transition (EMT) of malignant

83 Epithelial to mesenchymal transition (EMT) of retinal pi

84 dherens junctions, dedifferentiation, and an epithelial to mesenchymal transition (EMT) transcription

85 Cells were analyzed for markers of the epithelial to mesenchymal transition (EMT) using flow cy

86 ) a hormone related subtype, associated with Epithelial to Mesenchymal Transition (EMT), and gain of

87 harbor its receptor, leads to occurrence of epithelial to mesenchymal transition (EMT), in time and

88 After epithelial to mesenchymal transition (EMT), mesenchymal

89 ar event during embryonic development called epithelial to mesenchymal transition (EMT), we hypothesi

90 activation of several genes involved in the epithelial to mesenchymal transition (EMT).

91 breast cancer with histological evidence of epithelial to mesenchymal transition (EMT).

92 crest, an ectodermal cell population, via an epithelial to mesenchymal transition (EMT).

93 Esrp1 also regulates splicing during the epithelial to mesenchymal transition (EMT).

94 , which is indicative of an induction of the epithelial to mesenchymal transition (EMT).

95 trol of transcriptional programs such as the epithelial-to-mesenchymal transition (EMT) [7, 8].

96 nit, caused HME cells to undergo spontaneous epithelial-to-mesenchymal transition (EMT) and aberrant

97 em cells (CSC), able to be generated through epithelial-to-mesenchymal transition (EMT) and capable o

98 We demonstrate here a molecular link between epithelial-to-mesenchymal transition (EMT) and CD8(+) TI

99 tor beta (TGF-beta) is well known to promote epithelial-to-mesenchymal transition (EMT) and contribut

100 a (GBM) is, in part, attributed to increased epithelial-to-mesenchymal transition (EMT) and enhanced

101 sociated stroma mimics the gene signature of epithelial-to-mesenchymal transition (EMT) and found no

102 fic mutation in p18-deficient mice activates epithelial-to-mesenchymal transition (EMT) and induces d

103 riptional factor is essential for triggering epithelial-to-mesenchymal transition (EMT) and inducing

104 lso play essential roles in the induction of epithelial-to-mesenchymal transition (EMT) and induction

105 Two key cellular plasticity mechanisms -Epithelial-to-Mesenchymal Transition (EMT) and Mesenchym

106 egulation in cancer cells is associated with epithelial-to-mesenchymal transition (EMT) and metastati

107 , premigratory neural crest cells undergo an epithelial-to-mesenchymal transition (EMT) and migrate t

108 ognosis is potentially due to cancer-related epithelial-to-mesenchymal transition (EMT) and poor chem

109 r receptor (FGFR) upmodulation, resulting in epithelial-to-mesenchymal transition (EMT) and stem/prog

110 ional reprogramming of the cells, leading to epithelial-to-mesenchymal transition (EMT) and stimulati

111 s of markers for invasion, inflammation, and epithelial-to-mesenchymal transition (EMT) and that a su

112 ed progenitor cell (EPDC) formation requires epithelial-to-mesenchymal transition (EMT) and the subse

113 senchymal-to-epithelial transition (MET) and epithelial-to-mesenchymal transition (EMT) are important

114 estational diabetes also impaired epicardial epithelial-to-mesenchymal transition (EMT) as shown by a

115 , mammals) embryos, the deep layers arise by epithelial-to-mesenchymal transition (EMT) at a morpholo

116 Alu RNA induces epithelial-to-mesenchymal transition (EMT) by acting as

117 n-regulation of TRPS1 in TNBC cells promoted epithelial-to-mesenchymal transition (EMT) by deregulati

118 -3 supports the TIC/CSC state and induces an epithelial-to-mesenchymal transition (EMT) by driving ex

119 AMPK in inhibiting cancer-cell migration and epithelial-to-mesenchymal transition (EMT) by regulating

120 eltaCTD cells, but not CXCR4WT, exhibited an epithelial-to-mesenchymal transition (EMT) characterized

121 a master regulator of cellular identity and epithelial-to-mesenchymal transition (EMT) directly repr

122 can transcriptionally regulate SNAI1, a key epithelial-to-mesenchymal transition (EMT) driver, which

123 Snail family members regulate epithelial-to-mesenchymal transition (EMT) during invasi

124 emonstrated by the selection for programs of epithelial-to-mesenchymal transition (EMT) during malign

125 Epithelial-to-mesenchymal transition (EMT) enables scatt

126 man mammary epithelial cells that undergo an epithelial-to-mesenchymal transition (EMT) following tra

127 Transcriptome sequencing identified a strong epithelial-to-mesenchymal transition (EMT) gene signatur

128 Epithelial-to-mesenchymal transition (EMT) has been link

129 Phenotypic alteration in epithelial-to-mesenchymal transition (EMT) has been link

130 Epithelial-to-mesenchymal transition (EMT) has been prop

131 translational regulatory programs underlying epithelial-to-mesenchymal transition (EMT) in breast epi

132 Reversing epithelial-to-mesenchymal transition (EMT) in cancer cel

133 ZEB1 is best known for driving an epithelial-to-mesenchymal transition (EMT) in cancer cel

134 tion and polarized migration associated with epithelial-to-mesenchymal transition (EMT) in cancer req

135 Snail and Zeb transcription factors induce epithelial-to-mesenchymal transition (EMT) in embryonic

136 proposed that cyclosporin A (CsA) may induce epithelial-to-mesenchymal transition (EMT) in gingiva.

137 ession on the Wnt/beta-catenin signaling and epithelial-to-mesenchymal transition (EMT) in human CRC

138 Inducing epithelial-to-mesenchymal transition (EMT) in human ovar

139 The involvement of epithelial-to-mesenchymal transition (EMT) in metastasis

140 The role of epithelial-to-mesenchymal transition (EMT) in metastasis

141 oke, can induce proliferation, invasion, and epithelial-to-mesenchymal transition (EMT) in NSCLC cell

142 cent study has revealed that MT1-MMP induces epithelial-to-mesenchymal transition (EMT) in prostate a

143 prostate adenocarcinoma through induction of epithelial-to-mesenchymal transition (EMT) in Pten-null

144 olarized epithelial phenotype, and ESRP1, an epithelial-to-mesenchymal transition (EMT) inhibitor.

145 The epithelial-to-mesenchymal transition (EMT) is a cell bio

146 The epithelial-to-mesenchymal transition (EMT) is a cellular

147 Epithelial-to-mesenchymal transition (EMT) is a cellular

148 The epithelial-to-mesenchymal transition (EMT) is a complex

149 Epithelial-to-mesenchymal transition (EMT) is a core pro

150 idence indicates that aberrant regulation of epithelial-to-mesenchymal transition (EMT) is a determin

151 Epithelial-to-mesenchymal transition (EMT) is a developm

152 Epithelial-to-mesenchymal transition (EMT) is a dynamic

153 The epithelial-to-mesenchymal transition (EMT) is a highly c

154 Epithelial-to-mesenchymal transition (EMT) is a key proc

155 The epithelial-to-mesenchymal transition (EMT) is a reversib

156 ming growth factor beta 1 (TGFbeta1)-induced epithelial-to-mesenchymal transition (EMT) is accompanie

157 The epithelial-to-mesenchymal transition (EMT) is an essenti

158 Reversible epithelial-to-mesenchymal transition (EMT) is central to

159 e suggests that the developmental process of epithelial-to-mesenchymal transition (EMT) is co-opted b

160 Epithelial-to-mesenchymal transition (EMT) is critical f

161 use of cancer-related death in patients, and epithelial-to-mesenchymal transition (EMT) is essential

162 Alterations of epithelial-to-mesenchymal transition (EMT) marker expres

163 red to maintain expression of metastasis and Epithelial-to-mesenchymal transition (EMT) markers and t

164 Importantly, expression of key epithelial-to-mesenchymal transition (EMT) markers and u

165 a significant reduction in the expression of epithelial-to-mesenchymal transition (EMT) markers vimen

166 ssays together with qRT-PCR determination of epithelial-to-mesenchymal transition (EMT) markers were

167 n of the EOC cells and reduced expression of epithelial-to-mesenchymal transition (EMT) markers ZEB1,

168 monstrate that LRIG1 is downregulated during epithelial-to-mesenchymal transition (EMT) of human mamm

169 Depletion of NatD suppresses the epithelial-to-mesenchymal transition (EMT) of lung cance

170 h STAT4 mediated EOC metastasis via inducing epithelial-to-mesenchymal transition (EMT) of ovarian ca

171 Herein, we demonstrate that Stat5a/b induces epithelial-to-mesenchymal transition (EMT) of PC cells,

172 Kidney fibrosis is marked by an epithelial-to-mesenchymal transition (EMT) of tubular ep

173 in signaling, leading to the induction of an epithelial-to-mesenchymal transition (EMT) phenotype cha

174 Metastatic lung cancer cells can undergo an epithelial-to-mesenchymal transition (EMT) regulated by

175 The epithelial-to-mesenchymal transition (EMT) regulates the

176 ells to undergo VM and that knockdown of the epithelial-to-mesenchymal transition (EMT) regulator, Zi

177 esicular trafficking that is associated with epithelial-to-mesenchymal transition (EMT) remains uncle

178 ased migration phenotype along with enhanced epithelial-to-mesenchymal transition (EMT) signature aft

179 HRAS-induced epithelial-to-mesenchymal transition (EMT) through activ

180 e of the neural tube, these cells undergo an epithelial-to-mesenchymal transition (EMT) to delaminate

181 The contribution of epithelial-to-mesenchymal transition (EMT) to the profib

182 The epithelial-to-mesenchymal transition (EMT) transcription

183 cellular matrix organization, TGFbeta genes, epithelial-to-mesenchymal transition (EMT) transcription

184 asts is manifold, but the contribution of an epithelial-to-mesenchymal transition (EMT) undergone by

185 omoter methylation of three genes regulating epithelial-to-mesenchymal transition (EMT), a key mechan

186 adherin to N-cadherin is associated with the epithelial-to-mesenchymal transition (EMT), a process re

187 cells is a bona fide physiological model of epithelial-to-mesenchymal transition (EMT), a process th

188 twork of transcription factors that controls epithelial-to-mesenchymal transition (EMT), a reversible

189 eir clusters and become motile by undergoing epithelial-to-mesenchymal transition (EMT), an essential

190 cells lose PDX1 expression while undergoing epithelial-to-mesenchymal transition (EMT), and PDX1 los

191 During epithelial-to-mesenchymal transition (EMT), cells lining

192 of claudin-7 in HT-29 or DLD-1 cells induced epithelial-to-mesenchymal transition (EMT), colony forma

193 RNAi-mediated silencing of RASSF1A induced epithelial-to-mesenchymal transition (EMT), fomenting a

194 applied to a proposed 22-gene network of the Epithelial-to-Mesenchymal Transition (EMT), from which w

195 TGF-beta1 promoted epithelial-to-mesenchymal transition (EMT), invasion, Sm

196 oor prognosis owing to its role in promoting epithelial-to-mesenchymal transition (EMT), invasiveness

197 altered level or activity of p53, markers of epithelial-to-mesenchymal transition (EMT), or MIR34A or

198 SNAI1, TWIST1, and ZEB1, which regulate the epithelial-to-mesenchymal transition (EMT), promoted mes

199 n hepatocytes is associated with HCV-induced epithelial-to-mesenchymal transition (EMT), providing an

200 h suggested PrP and ZIP6 are critical during epithelial-to-mesenchymal transition (EMT), we investiga

201 e miRNA-200 family (miR-200f), regulators of epithelial-to-mesenchymal transition (EMT), we pinpoint

202 derstood about the contribution of lncRNA to epithelial-to-mesenchymal transition (EMT), which correl

203 pithelial ovarian cancer (EOC) cells undergo epithelial-to-mesenchymal transition (EMT), which influe

204 Metastatic breast tumors undergo epithelial-to-mesenchymal transition (EMT), which render

205 ny tissue types, metastasis is fueled by the epithelial-to-mesenchymal transition (EMT)-a dynamic pro

206 A number of epithelial-to-mesenchymal transition (EMT)-associated ge

207 difficult to treat, especially the squamous/epithelial-to-mesenchymal transition (EMT)-like subtype.

208 Changes in the expression of epithelial-to-mesenchymal transition (EMT)-related molec

209 3K27me3), and inhibition of genes related to epithelial-to-mesenchymal transition (EMT).

210 Pten deletion during cell transformation and epithelial-to-mesenchymal transition (EMT).

211 rior to EHT, in a striking parallel with the epithelial-to-mesenchymal transition (EMT).

212 sistent with a general function in promoting epithelial-to-mesenchymal transition (EMT).

213 IN, being this profile characteristic of the epithelial-to-mesenchymal transition (EMT).

214 anges of expression of genes associated with epithelial-to-mesenchymal transition (EMT).

215 e expression of Zeb1, a key regulator of the epithelial-to-mesenchymal transition (EMT).

216 due to its role as a transcription factor in epithelial-to-mesenchymal transition (EMT).

217 ays show that they act as suppressors of the epithelial-to-mesenchymal transition (EMT).

218 est cells arise from the head neural tube by epithelial-to-mesenchymal transition (EMT).

219 increased motility and invasiveness through epithelial-to-mesenchymal transition (EMT).

220 pithelium into a tube that will then undergo epithelial-to-mesenchymal transition (EMT).

221 nd activation of the AXL tyrosine kinase and epithelial-to-mesenchymal transition (EMT).

222 e progression of metastatic cancer along the epithelial-to-mesenchymal transition (EMT).

223 which loss of the BRMS1 gene contributes to epithelial-to-mesenchymal transition (EMT).

224 microenvironment aid in the induction of the epithelial-to-mesenchymal transition (EMT).

225 cytoskeleton reorganization and induction of epithelial-to-mesenchymal transition (EMT).

226 the switch between E- and N-cadherins during epithelial-to-mesenchymal transition (EMT).

227 of progenitors, Shh pathway activation, and epithelial-to-mesenchymal transition (EMT).

228 Snail and Mmp-3 mRNAs, and the induction of epithelial-to-mesenchymal transition (EMT).

229 controls TGF-beta-induced growth arrest and epithelial-to-mesenchymal transition (EMT).

230 maturation and exhibit changes that resemble epithelial-to-mesenchymal transition (EMT).

231 expression of EFA6B hampered TGFbeta-induced epithelial-to-mesenchymal transition (EMT).

232 E-cadherin promoter and are key mediators of epithelial-to-mesenchymal transition (EMT).

233 ing invasive migration, drug resistance, and epithelial-to-mesenchymal transition (EMT).

234 ated, and miRNA-depleted CDs undergo partial epithelial-to-mesenchymal transition (EMT).

235 y reactivating a latent embryonic programme: epithelial-to-mesenchymal transition (EMT).

236 ation of the mesoderm after the gastrulation epithelial-to-mesenchymal transition (EMT).

237 d altered the expression of genes related to epithelial-to-mesenchymal transition (EMT).

238 of TGFbeta by limiting its ability to induce epithelial-to-mesenchymal transition (EMT).

239 (Hh) and MET signaling cascades driving the epithelial-to-mesenchymal transition (EMT).

240 The FAM3C interleukin-like epithelial-to-mesenchymal-transition (EMT) inducer (ILEI

241 fumarate in mouse and human cells elicits an epithelial-to-mesenchymal-transition (EMT), a phenotypic

242 During epithelial-to-mesenchymal transitions (EMTs), cells disa

243 The epithelial-to-mesenchymal transition enables carcinoma c

244 Moreover, it suppressed IR-induced epithelial-to-mesenchymal transition, expressions of NF-

245 cific long non-coding RNA that modulates the epithelial-to-mesenchymal transition, facilitates cell m

246 types and correlates with the expression of epithelial-to-mesenchymal transition gene signature, a f

247 ded by ALDH5A1), and with the presence of an epithelial-to-mesenchymal transition gene signature, imp

248 ian cancer and positively correlated with an epithelial-to-mesenchymal transition gene signature.

249 Differentiated tumor cells induced the epithelial to mesenchymal transition in colonosperes; th

250 nization and polarity and, notably, abnormal epithelial to mesenchymal transition in the lens.

251 ly, we identified FZD4, a gene important for epithelial-to-mesenchymal transition in (PCa), as a targ

252 Because HMGA1 promotes epithelial-to-mesenchymal transition in cancer, we hypot

253 how plastic CSCs are, and the importance of epithelial-to-mesenchymal transition in conferring CSC p

254 of IL-8 after 24 hours, but possibly induces epithelial-to-mesenchymal transition in epithelial cells

255 ted hepatocyte growth factor facilitated the epithelial-to-mesenchymal transition in HepG2 cells.

256 activation of latent TGF-beta and subsequent epithelial-to-mesenchymal transition in mammary epitheli

257 eptor (ET(A)R) by endothelin-1 (ET-1) drives epithelial-to-mesenchymal transition in ovarian tumor ce

258 Enrichment analysis suggested epithelial-to-mesenchymal transition in RKO cells, as ev

259 ular vesicles to promote tumor induction and epithelial-to-mesenchymal transition in vitro and in viv

260 ortantly, microenvironment stimuli eliciting epithelial-to-mesenchymal transition, including signals

261 cally, we found that ABHD5 knockdown induces epithelial to mesenchymal transition, increasing aerobic

262 etastatic spread through Rac1 activation and epithelial-to-mesenchymal transition, independently of a

263 in a TGF-beta-dependent manner and promotes epithelial to mesenchymal transition indicating that hig

264 derstanding how radiotherapy upregulates the epithelial to mesenchymal transition-inducer Snail1.

265 others previously established that the Slug epithelial-to-mesenchymal transition-inducing transcript

266 growth control, enhanced cellular survival, epithelial-to-mesenchymal transition, invasion, and meta

267 Epithelial to mesenchymal transition is a common event d

268 Epithelial-to-mesenchymal transition is implicated in me

269 reased fibronectin expression, a hallmark of epithelial-to-mesenchymal transition, is associated with

270 ial for stimulating stem cells to undergo an epithelial to mesenchymal transition-like process necess

271 ession is the epigenetic reprogramming of an epithelial-to-mesenchymal transition-like (EMT) change t

272 resulted in generation of highly metastatic epithelial-to-mesenchymal transition-like cancer stem ce

273 In addition, overexpression of Runx2 drove epithelial-to-mesenchymal transition-like changes in nor

274 d -GLI2 cells expressed higher levels of the epithelial-to-mesenchymal transition markers Snail and v

275 Concurrently, the proteins associated with epithelial-to-mesenchymal transition, N-cadherin and Vim

276 n of MRC-5 fibroblasts and TGF-beta-mediated epithelial-to-mesenchymal transition of A549 cells by in

277 n the proliferation, survival, migration and epithelial-to-mesenchymal transition of cancer cells.

278 is frequently citrullinated in cells during epithelial-to-mesenchymal transition of metastasizing ep

279 and transforming growth factor beta-induced epithelial-to-mesenchymal transition of SKOV-3 cells.

280 ound to promote and/or maintain the state of epithelial to mesenchymal transition on CTCs through pla

281 to tumorigenesis including TGF-beta induced epithelial-to-mesenchymal transition on NMuMG cells and

282 xia, epithelial differentiation, and partial epithelial-to-mesenchymal transition (p-EMT).

283 In the absence of USP9X, cells exhibited an epithelial-to-mesenchymal transition phenotype, acquired

284 d enhances cell migration especially in post-epithelial-to-mesenchymal transition (post-EMT) cancer c

285 to their increased expression of stem cell, epithelial-to-mesenchymal transition, pro-survival, and

286 eta-catenin and TGF-beta signalling, and pro-epithelial-to-mesenchymal transition/pro-metastatic prot

287 p53 inactivation activates a cell-autonomous epithelial-to-mesenchymal transition program leading to

288 x degradation pathways shows that p63 blocks epithelial-to-mesenchymal transition, promotes a CTB-spe

289 cell lines and found that metastasis-related epithelial to mesenchymal transition properties of BRAFi

290 proteins and with an increased expression of epithelial-to-mesenchymal transition-related genes.

291 finger transcription factor Snail1 regulates epithelial to mesenchymal transition, repressing epithel

292 n breast cancer cells increased MEK-EMT (MEK-epithelial-to-mesenchymal transition) signaling, transwe

293 ected MIUCB was enriched in genes that drive epithelial-to-mesenchymal transition, the upregulation o

294 C-like cells, with these cells undergoing an epithelial-to-mesenchymal transition to form clonogenic,

295 e central nervous system but then undergo an epithelial-to-mesenchymal transition to migrate away and

296 and differentiation, resistance to anoikis, epithelial-to-mesenchymal transition, tumor cell dormanc

297 volved in stemness, differentiation, and the epithelial to mesenchymal transition was measured using

298 However, importantly, NAMPT-induced epithelial-to-mesenchymal transition was found to be ind

299 vitro-derived epicardial cells underwent an epithelial-to-mesenchymal transition when treated with P

300 Gd@C82(OH)22 blocks epithelial-to-mesenchymal transition with resultant effi